Some more news about (useful implementation of) CRISPR technology.
MIT researchers have developed a way to deliver the CRISPR genome repair components more efficiently than previously possible, and they also believe it may be safer for human use. In a study of mice, they found that they could correct the mutated gene that causes a rare liver disorder, in 6 percent of liver cells — enough to cure the mice of the disease, known as tyrosinemia.
http://news.mit.edu/2016/crispr-curing-disease-repairing-faulty-genes-0201
MIT researchers have developed a way to deliver the CRISPR genome repair components more efficiently than previously possible, and they also believe it may be safer for human use. In a study of mice, they found that they could correct the mutated gene that causes a rare liver disorder, in 6 percent of liver cells — enough to cure the mice of the disease, known as tyrosinemia.
http://news.mit.edu/2016/crispr-curing-disease-repairing-faulty-genes-0201